FDA-Drug2026-02-18Class IIIMISBRANDING
Unichem Doxazosin 4 mg tablets recalled for incorrect imprint labeling
What this means
Unichem Pharmaceuticals distributed 60,000 tablets of Doxazosin 4 mg with incorrect imprinting on the tablets themselves. This labeling error could cause confusion about the medication's identity and strength. The affected lot is GDSH25006, which expires in August 2027.
- Check your Doxazosin bottle for lot number GDSH25006.
- If you have this lot, contact your pharmacist or doctor before taking any more doses.
- Do not use tablets from this lot without speaking to your healthcare provider first.
- Return the bottle to your pharmacy for safe disposal or replacement.
The agency's original wording
Hazard
Tablets/Capsules Imprinted with Wrong ID
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide
Affected count
60,000 tablets
Manufactured in
1 Tower Center Blvd Ste 2200, N/A, East Brunswick, NJ, United States
Products
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0306-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.